Stock Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh by November 8, 2024 written by November 8, 2024 Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com 0 comment 0 FacebookTwitterPinterestEmail previous post Richemont shares fall amid sluggish China demand, margin pressures next post TSMC to suspend production of advanced AI chips for China from Monday, FT reports You may also like Adani, Ambani news units sue OpenAI over copyright,... March 13, 2026 China’s DeepSeek sets off AI market rout March 13, 2026 BASF results down on impairments, restructuring March 13, 2026 Nasdaq futures tumble as China’s AI push rattles... March 13, 2026 European chipmakers slump as traders gauge DeepSeek AI... March 13, 2026 Fuji Media, rocked by sexual misconduct allegations, says... March 13, 2026 China Vanke’s CEO, chairman resign amid growing liquidity... March 13, 2026 Italy’s MPS shares fall ahead of Mediobanca board... March 13, 2026 UMG shares rally after new multi-year pact with... March 13, 2026 British Land stock drops following stake sale March 13, 2026